Cowen to host 41st Annual Health Care Conference on March 1-4, 2021. Click here for more information.

$905 Million

Nautilus Biotechnology

Sell-side

Financial Advisor, February 2021

Combination with ARYA Sciences Acquisition Corp III

Nautilus’ mission is to transform the field of proteomics, unlocking access to the proteome and enabling fundamental advancements in biology, human health, and medicine. The Company’s vision is to integrate their breakthrough innovations in computer science, engineering, and biochemistry to develop and commercialize a proteomic analysis technology of high sensitivity and scale. To accomplish this, they have designed a single molecule proteomic analysis system to deliver the speed, simplicity, accuracy, and versatility that is necessary to establish a new gold standard in the field.

ARYA Sciences Acquisition Corp. III is a special purpose acquisition corporation incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. ARYA’s sponsor is an affiliate of Perceptive Advisors, a leading life sciences focused investment firm with over $7 billion of regulatory assets under management as of December 31, 2019.

More Like This

Dec 2020
$3.9 Billion
Tilray Logo

Combination with Aphria Inc.

Financial Advisor

View Details
Sep 2020
$21 Billion

Sale to Gilead Sciences

Financial Advisor

View Details
Sep 2020

Sale to NORD Holding Unternehmensbeteiligungsgesellschaft mbH

Financial Advisor

View Details